Editor: NOEL GONZÁLEZ GOTERA Número 120 Diseño: Lic. Roberto Chávez y Liuder Machado. Semana 250114 – 310114 oto: Lic. Belkis Romeu e Instituto Finlay La Habana, Cuba.

ARTÍCULOS CIENTÍFICOS

Publicaciones incluidas en PubMED durante el período comprendido entre el 24 y el 31 de enero 2014. Con “vaccin*” en título: 124 artículos recuperados.

Vacunas Meningococo (Neisseria meningitidis)

20. [Invasive meningococcal disease in the Czech Republic - analysis of the epidemiological situation and vaccination strategy recommendations].

Křížová P, Vacková Z, Musílek M, Kozáková J.

Epidemiol Mikrobiol Imunol. 2013 Dec;62(4):138-47. Czech.

PMID: 24467175 [PubMed - in process]

Related citations

Select item 24467174

114. Will booster doses be required for serogroup B meningococcal vaccine?

McQuaid F, Snape MD.

Expert Rev Vaccines. 2014 Jan 23. [Epub ahead of print]

PMID: 24451002 [PubMed - as supplied by publisher]

Related citations

Select item 24450996

1

Vacunas BCG – ONCO BCG (Mycobacterium bovis)

27. Tuberculin Skin Test Distribution following a Change in BCG Vaccination Policy.

Lee SW, Oh SY, Lee JB, Choi CM, Kim HJ.

PLoS One. 2014 Jan 23;9(1):e86419. doi: 10.1371/journal.pone.0086419. eCollection 2014 Jan 23.

PMID: 24466082 [PubMed - in process] Free Article

Related citations

Select item 24465991

Vacunas Neumococo (Streptococcus pneumoniae)

19. High invasiveness of pneumococcal serotypes included in the new generation of conjugate vaccines.

Del Amo E, Brotons P, Monsonis M, Triviño M, Iñigo M, Selva L, Sa-Leão R, Muñoz-Almagro C.

Clin Microbiol Infect. 2013 Oct 6. doi: 10.1111/1469-0691.12422. [Epub ahead of print]

PMID: 24467648 [PubMed - as supplied by publisher]

Related citations

Select item 24467175

24. Influenza and pneumococcal vaccinations in dialysis patients in a London district general hospital.

Wilmore SM, Philip KE, Cambiano V, Bretherton CP, Harborne JE, Sharma A, Jayasena SD.

Clin Kidney J. 2014 Feb;7(1):27-32. Epub 2013 Dec 1.

PMID: 24466425 [PubMed]

Related citations

Select item 24466157

29. Age-Dependent Prevalence of Nasopharyngeal Carriage of Streptococcus pneumoniae before Introduction: A Prediction Model Based on a Meta-Analysis.

Le Polain de Waroux O, Flasche S, Prieto-Merino D, Edmunds WJ.

PLoS One. 2014 Jan 23;9(1):e86136. doi: 10.1371/journal.pone.0086136. eCollection 2014 Jan 23.

PMID: 24465920 [PubMed - in process] 2

Free Article

Related citations

Select item 24465739

31. Immunogenicity, Impact on Carriage and Reactogenicity of 10-Valent Pneumococcal Non- Typeable Haemophilus influenzae Protein D Conjugate Vaccine in Kenyan Children Aged 1-4 Years: A Randomized Controlled Trial.

Hammitt LL, Ojal J, Bashraheil M, Morpeth SC, Karani A, Habib A, Borys D, Goldblatt D, Scott JA.

PLoS One. 2014 Jan 21;9(1):e85459. doi: 10.1371/journal.pone.0085459. eCollection 2014 Jan 21.

PMID: 24465570 [PubMed - in process] Free Article

Related citations

Select item 24465562

36. Nasopharyngeal Carriage and Transmission of Streptococcus pneumoniae in American Indian Households after a Decade of Pneumococcal Conjugate Vaccine Use.

Mosser JF, Grant LR, Millar EV, Weatherholtz RC, Jackson DM, Beall B, Craig MJ, Reid R, Santosham M, O'Brien KL.

PLoS One. 2014 Jan 17;9(1):e79578. doi: 10.1371/journal.pone.0079578. eCollection 2014 Jan 17.

PMID: 24465365 [PubMed - in process] Free Article

Related citations

Select item 24465269

47. Trends in Asymptomatic Nasopharyngeal Colonization with Streptococcus pneumoniae After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Calgary, Canada.

Ricketson LJ, Wood ML, Vanderkooi OG, Macdonald JC, Martin IE, Demczuk WH, Kellner JD; for the Calgary Streptococcus pneumoniae Epidemiology Research (CASPER) investigators.

Pediatr Infect Dis J. 2014 Jan 23. [Epub ahead of print]

PMID: 24463806 [PubMed - as supplied by publisher]

Related citations

Select item 24463801

68. Impact of 13-valent pneumococcal conjugate vaccine on otitis media bacteriology.

Zhao AS, Boyle S, Butrymowicz A, Engle RD, Roberts JM, Mouzakes J. 3

Int J Pediatr Otorhinolaryngol. 2014 Jan 5. pii: S0165-5876(13)00674-5. doi: 10.1016/j.ijporl.2013.12.028. [Epub ahead of print]

PMID: 24461461 [PubMed - as supplied by publisher]

Related citations

Select item 24461316

92. Impact of pneumococcal vaccines use on invasive pneumococcal disease in Nunavik (Quebec) from 1997 to 2010.

Le Meur JB, Lefebvre B, Proulx JF, Déry S, Pépin J, De Wals P.

Int J Circumpolar Health. 2014 Jan 17;73. doi: 10.3402/ijch.v73.22691. eCollection 2014 Jan 17.

PMID: 24455492 [PubMed - in process]

Free PMC Article

Related citations

Select item 24455487

95. Potential cost-effectiveness of a new infant tuberculosis vaccine in South Africa - implications for clinical trials: a decision analysis.

Ditkowsky JB, Schwartzman K.

PLoS One. 2014 Jan 15;9(1):e83526. doi: 10.1371/journal.pone.0083526. eCollection 2014 Jan 15.

PMID: 24454706 [PubMed - in process] Free PMC Article

Related citations

Select item 24454591

113. Changes in Streptococcus pneumoniae Serotypes in the Nasopharynx of Japanese Children after Inoculation with a Heptavalent Pneumococcal Conjugate Vaccine.

Ueno M, Ishii Y, Tateda K, Anahara Y, Ebata A, Iida M, Mizuno F, Inamura S, Takahata K, Suzuki Y, Chang B, Wada A, Sugita M, Tanaka T, Nishiwaki Y.

Jpn J Infect Dis. 2014;67(1):40-3.

PMID: 24451100 [PubMed - in process] Free Article

Related citations

Select item 24451002

4

124. Improving pneumococcal and herpes zoster vaccination uptake: expanding pharmacist privileges.

Taitel MS, Fensterheim LE, Cannon AE, Cohen ES.

Am J Manag Care. 2013 Sep;19(9):e309-13.

PMID: 24449960 [PubMed - in process] Related citations

Vacuna Tosferina (Bordetella pertussis)

82. Consistency of Bordetella pertussis vaccine seed strains and potency of whole-cell pertussis vaccine still in use in Poland.

Zawadka M, Mosiej E, Polak M, Krysztopa-Grzybowska K, Moskała B, Rokosz-Chudziak N, Rabczenko D, Augustynowicz E, Lutyńska A.

Biologicals. 2014 Jan 20. pii: S1045-1056(13)00138-3. doi: 10.1016/j.biologicals.2013.11.006. [Epub ahead of print]

PMID: 24457195 [PubMed - as supplied by publisher]

Related citations

Select item 24456962

Vacuna Tuberculosis (Mycobacterium tuberculosis)

18. In silico analysis of potential human T Cell antigens from Mycobacterium tuberculosis for the development of subunit vaccines against tuberculosis.

Devasundaram S, Deenadayalan A, Raja A.

Immunol Invest. 2014;43(2):137-59. doi: 10.3109/08820139.2013.857353.

PMID: 24467664 [PubMed - in process]

Related citations

Select item 24467648

96. A neonatal oral Mycobacterium tuberculosis-SIV prime / intramuscular MVA-SIV boost combination vaccine induces both SIV and Mtb-specific immune responses in infant macaques.

Jensen K, Pena MG, Wilson RL, Ranganathan UD, Jacobs WR Jr, Fennelly G, Larsen M, Van Rompay KK, Kozlowski PA, Abel K.

Trials Vaccinol. 2013 Nov 1;2:53-63.

PMID: 24454591 [PubMed]

5

Related citations

Select item 24454475

118. Novel approaches to tuberculosis prevention: DNA vaccines.

Rivas-Santiago B, Cervantes-Villagrana AR.

Scand J Infect Dis. 2014 Jan 23. [Epub ahead of print]

PMID: 24450840 [PubMed - as supplied by publisher]

Related citations

Select item 24450591

Adyuvantes

30. Characterization of the structure and immunostimulatory activity of a vaccine adjuvant, de-o- acylated lipooligosaccharide.

Han JE, Wui SR, Kim KS, Cho YJ, Cho WJ, Lee NG.

PLoS One. 2014 Jan 22;9(1):e85838. doi: 10.1371/journal.pone.0085838. eCollection 2014 Jan 22.

PMID: 24465739 [PubMed - in process] Free Article

Related citations

Select item 24465570

49. Immunomodulatory properties of the vaccine adjuvant alum.

Oleszycka E, Lavelle EC.

Curr Opin Immunol. 2014 Jan 22;28C:1-5. doi: 10.1016/j.coi.2013.12.007. [Epub ahead of print]

PMID: 24463269 [PubMed - as supplied by publisher]

Related citations

Select item 24463109

Vacunas, otras

1. Development of a new trend conjugate vaccine for the prevention of Klebsiella pneumoniae.

Ahmad TA, Haroun M, Hussein AA, El Ashry ES, El-Sayed LH.

Infect Dis Rep. 2012 Jul 23;4(2):e33. eCollection 2012 Apr 27. Review.

6

PMID: 24470947 [PubMed - as supplied by publisher]

Related citations

Select item 24470671 2.

Hydroa vacciniforme-like cutaneous T-cell lymphoma.

Shi JQ, Chen QX, Li SF, Li W.

Indian J Dermatol. 2014 Jan;59(1):91-3. doi: 10.4103/0019-5154.123516.

PMID: 24470671 [PubMed]

Related citations

Select item 24470276 3.

Herpes zoster caused by vaccine strain varicella zoster virus in an immunocompetent recipient of zoster vaccine.

Tseng HF, Schmid DS, Harpaz R, Larussa P, Jensen NJ, Rivailler P, Radford K, Folster J, Jacobsen SJ.

Clin Infect Dis. 2014 Jan 26. [Epub ahead of print]

PMID: 24470276 [PubMed - as supplied by publisher]

Related citations

Select item 24469971 4.

Factors related to Israeli lesbian women's intention to be vaccinated against human papillomavirus.

Ben-Natan M, Maor S.

Int J STD AIDS. 2014 Jan 27. [Epub ahead of print]

PMID: 24469971 [PubMed - as supplied by publisher]

Related citations

7

Select item 24469907 5.

Novel Hollow Microneedle Technology for Depth-Controlled Microinjection-Mediated Dermal Vaccination: A Study with Polio Vaccine in Rats. van der Maaden K, Trietsch SJ, Kraan H, Varypataki EM, Romeijn S, Zwier R, van der Linden HJ, Kersten G, Hankemeier T, Jiskoot W, Bouwstra J.

Pharm Res. 2014 Jan 28. [Epub ahead of print]

PMID: 24469907 [PubMed - as supplied by publisher]

Related citations

Select item 24469815 6.

Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections.

Chen JR, Yu YH, Tseng YC, Chiang WL, Chiang MF, Ko YA, Chiu YK, Ma HH, Wu CY, Jan JT, Lin KI, Ma C, Wong CH.

Proc Natl Acad Sci U S A. 2014 Jan 27. [Epub ahead of print]

PMID: 24469815 [PubMed - as supplied by publisher]

Related citations

Select item 24469811 7.

Identification and characterization of the constituent human serum antibodies elicited by vaccination.

Lavinder JJ, Wine Y, Giesecke C, Ippolito GC, Horton AP, Lungu OI, Hoi KH, Dekosky BJ, Murrin EM, Wirth MM, Ellington AD, Dörner T, Marcotte EM, Boutz DR, Georgiou G.

Proc Natl Acad Sci U S A. 2014 Jan 27. [Epub ahead of print]

PMID: 24469811 [PubMed - as supplied by publisher]

Related citations

Select item 24469503 8.

8

HSV-2 Vaccine: Current Status and Insight into Factors for Developing an Efficient Vaccine.

Zhu XP, Muhammad ZS, Wang JG, Lin W, Guo SK, Zhang W.

Viruses. 2014 Jan 24;6(2):371-90. doi: 10.3390/v6020371.

PMID: 24469503 [PubMed - in process]

Related citations

Select item 24469391 9.

Acute thrombotic thrombocytopenic purpura after pneumococcal vaccination.

Kojima Y, Ohashi H, Nakamura T, Nakamura H, Yamamoto H, Miyata Y, Iida H, Nagai H.

Blood Coagul Fibrinolysis. 2014 Jan 24. [Epub ahead of print]

PMID: 24469391 [PubMed - as supplied by publisher]

Related citations

Select item 24469287 10.

Rotavirus vaccination : A risk factor for intussusception?

Oberle D, Jenke AC, von Kries R, Mentzer D, Keller-Stanislawski B.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Feb;57(2):234-241.

PMID: 24469287 [PubMed - as supplied by publisher]

Related citations

Select item 24469120 11.

[Detection of the exogenous gene copy number of the transgenic tomato anti-caries vaccine].

Bai GH, Liu JG, Tian Y, Chen Z, Bai PY, Han Q, Gu Y, Guan XY, Wang HH.

Shanghai Kou Qiang Yi Xue. 2013 Dec;22(6):613-7. Chinese.

9

PMID: 24469120 [PubMed - in process]

Related citations

Select item 24468996 12.

Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy.

Simani OE, Izu A, Violari A, Cotton MF, van Niekerk N, Adrian PV, Madhi SA.

AIDS. 2014 Feb 20;28(4):531-41. doi: 10.1097/QAD.0000000000000127.

PMID: 24468996 [PubMed - in process]

Related citations

Select item 24468629 13.

Improved storage stability and immunogenicity of hepatitis B vaccine after spray- freeze drying in presence of sugars.

Tonnis WF, Amorij JP, Vreeman MA, Frijlink HW, Kersten GF, Hinrichs WL.

Eur J Pharm Sci. 2014 Jan 24. pii: S0928-0987(14)00020-7. doi: 10.1016/j.ejps.2014.01.005. [Epub ahead of print]

PMID: 24468629 [PubMed - as supplied by publisher]

Related citations

Select item 24468494 14.

Novel insights on the progression of intermediate viral forms in the morphogenesis of vaccinia virus.

Cepeda V, Esteban M.

Virus Res. 2014 Jan 24. pii: S0168-1702(14)00030-6. doi: 10.1016/j.virusres.2014.01.016. [Epub ahead of print]

PMID: 24468494 [PubMed - as supplied by publisher]

10

Related citations

Select item 24468416 15.

On the relationship between human papilloma virus vaccine and autoimmune diseases.

Pellegrino P, Carnovale C, Pozzi M, Antoniazzi S, Perrone V, Salvati D, Gentili M, Brusadelli T, Clementi E, Radice S.

Autoimmun Rev. 2014 Jan 24. pii: S1568-9972(14)00066-4. doi: 10.1016/j.autrev.2014.01.054. [Epub ahead of print]

PMID: 24468416 [PubMed - as supplied by publisher]

Related citations

Select item 24468101 16.

Childhood narcolepsy with cataplexy: comparison between post-H1N1 vaccination and sporadic cases.

Fabio P, Peltola H, Sarkanen T, Moghadam KK, Plazzi G, Partinen M.

Sleep Med. 2013 Dec 1. pii: S1389-9457(13)01214-8. doi: 10.1016/j.sleep.2013.09.021. [Epub ahead of print]

PMID: 24468101 [PubMed - as supplied by publisher]

Related citations

Select item 24467929 17.

Recombinant LipL32 stimulates interferon-gamma production in cattle vaccinated with a monovalent Leptospira borgpetersenii serovar Hardjo subtype Hardjobovis vaccine.

Deveson Lucas DS, Lo M, Bulach DM, Quinsey NS, Murray GL, Allen A, Adler B.

Vet Microbiol. 2014 Jan 4. pii: S0378-1135(13)00594-4. doi: 10.1016/j.vetmic.2013.12.016. [Epub ahead of print]

PMID: 24467929 [PubMed - as supplied by publisher]

Related citations

11

Select item 24467664 18.

In silico analysis of potential human T Cell antigens from Mycobacterium tuberculosis for the development of subunit vaccines against tuberculosis.

Devasundaram S, Deenadayalan A, Raja A.

Immunol Invest. 2014;43(2):137-59. doi: 10.3109/08820139.2013.857353.

PMID: 24467664 [PubMed - in process]

Related citations

Select item 24467648 19.

High invasiveness of pneumococcal serotypes included in the new generation of conjugate vaccines.

Del Amo E, Brotons P, Monsonis M, Triviño M, Iñigo M, Selva L, Sa-Leão R, Muñoz- Almagro C.

Clin Microbiol Infect. 2013 Oct 6. doi: 10.1111/1469-0691.12422. [Epub ahead of print]

PMID: 24467648 [PubMed - as supplied by publisher]

Related citations

Select item 24467175 20.

[Invasive meningococcal disease in the Czech Republic - analysis of the epidemiological situation and vaccination strategy recommendations].

Křížová P, Vacková Z, Musílek M, Kozáková J.

Epidemiol Mikrobiol Imunol. 2013 Dec;62(4):138-47. Czech.

PMID: 24467175 [PubMed - in process]

Related citations

Select item 24467174 21.

Rotavirus gastroenteritis in the Czech Republic before the start of vaccination.

12

Pazdiora P, Beneš C.

Epidemiol Mikrobiol Imunol. 2013 Winter;62(4):131-137.

PMID: 24467174 [PubMed - as supplied by publisher]

Related citations

Select item 24466581 22.

Synthetic carbohydrate antigens for HIV vaccine design.

Wang LX.

Curr Opin Chem Biol. 2013 Dec;17(6):997-1005.

PMID: 24466581 [PubMed - in process]

Related citations

Select item 24466565 23.

County-level estimates of human papillomavirus vaccine coverage among young adult women in Texas, 2008.

Eberth JM, Zhang X, Hossain M, Tiro JA, Holt JB, Vernon SW.

Tex Public Health J. 2013 Jan;65(1):37-40.

PMID: 24466565 [PubMed]

Related citations

Select item 24466425 24.

Influenza and pneumococcal vaccinations in dialysis patients in a London district general hospital.

Wilmore SM, Philip KE, Cambiano V, Bretherton CP, Harborne JE, Sharma A, Jayasena SD.

Clin Kidney J. 2014 Feb;7(1):27-32. Epub 2013 Dec 1.

PMID: 24466425

13

[PubMed]

Related citations

Select item 24466157 25.

Protective Effects of Membrane-Anchored and Secreted DNA Vaccines Encoding Fatty Acid-Binding Protein and Glutathione S-Transferase against Schistosoma japonicum.

Tu Y, Hu Y, Fan G, Chen Z, Liu L, Man D, Liu S, Tang C, Zhang Y, Dai W.

PLoS One. 2014 Jan 23;9(1):e86575. doi: 10.1371/journal.pone.0086575. eCollection 2014 Jan 23.

PMID: 24466157 [PubMed - in process] Free Article

Related citations

Select item 24466156 26.

Induction of Neutralizing Antibodies against Four Serotypes of Dengue Viruses by MixBiEDIII, a Tetravalent Dengue Vaccine.

Zhao H, Jiang T, Zhou XZ, Deng YQ, Li XF, Chen SP, Zhu SY, Zhou X, Qin ED, Qin CF.

PLoS One. 2014 Jan 21;9(1):e86573. doi: 10.1371/journal.pone.0086573. eCollection 2014 Jan 21.

PMID: 24466156 [PubMed - in process] Free Article

Related citations

Select item 24466082 27.

Tuberculin Skin Test Distribution following a Change in BCG Vaccination Policy.

Lee SW, Oh SY, Lee JB, Choi CM, Kim HJ.

PLoS One. 2014 Jan 23;9(1):e86419. doi: 10.1371/journal.pone.0086419. eCollection 2014 Jan 23.

PMID: 24466082 [PubMed - in process] Free Article

14

Related citations

Select item 24465991 28.

Altered Response Hierarchy and Increased T-Cell Breadth upon HIV-1 Conserved Element DNA Vaccination in Macaques.

Kulkarni V, Valentin A, Rosati M, Alicea C, Singh AK, Jalah R, Broderick KE, Sardesai NY, Le Gall S, Mothe B, Brander C, Rolland M, Mullins JI, Pavlakis GN, Felber BK.

PLoS One. 2014 Jan 23;9(1):e86254. doi: 10.1371/journal.pone.0086254. eCollection 2014 Jan 23.

PMID: 24465991 [PubMed - in process] Free Article

Related citations

Select item 24465920 29.

Age-Dependent Prevalence of Nasopharyngeal Carriage of Streptococcus pneumoniae before Conjugate Vaccine Introduction: A Prediction Model Based on a Meta-Analysis.

Le Polain de Waroux O, Flasche S, Prieto-Merino D, Edmunds WJ.

PLoS One. 2014 Jan 23;9(1):e86136. doi: 10.1371/journal.pone.0086136. eCollection 2014 Jan 23.

PMID: 24465920 [PubMed - in process] Free Article

Related citations

Select item 24465739 30.

Characterization of the structure and immunostimulatory activity of a vaccine adjuvant, de-o-acylated lipooligosaccharide.

Han JE, Wui SR, Kim KS, Cho YJ, Cho WJ, Lee NG.

PLoS One. 2014 Jan 22;9(1):e85838. doi: 10.1371/journal.pone.0085838. eCollection 2014 Jan 22.

PMID: 24465739 [PubMed - in process] Free Article

15

Related citations

Select item 24465570 31.

Immunogenicity, Impact on Carriage and Reactogenicity of 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine in Kenyan Children Aged 1-4 Years: A Randomized Controlled Trial.

Hammitt LL, Ojal J, Bashraheil M, Morpeth SC, Karani A, Habib A, Borys D, Goldblatt D, Scott JA.

PLoS One. 2014 Jan 21;9(1):e85459. doi: 10.1371/journal.pone.0085459. eCollection 2014 Jan 21.

PMID: 24465570 [PubMed - in process] Free Article

Related citations

Select item 24465562 32.

Did vaccination slow the spread of bluetongue in france?

Pioz M, Guis H, Pleydell D, Gay E, Calavas D, Durand B, Ducrot C, Lancelot R.

PLoS One. 2014 Jan 21;9(1):e85444. doi: 10.1371/journal.pone.0085444. eCollection 2014 Jan 21.

PMID: 24465562 [PubMed - in process] Free Article

Related citations

Select item 24465551 33.

Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity.

El Ridi R, Tallima H, Selim S, Donnelly S, Cotton S, Gonzales Santana B, Dalton JP.

PLoS One. 2014 Jan 21;9(1):e85401. doi: 10.1371/journal.pone.0085401. eCollection 2014 Jan 21.

PMID: 24465551 [PubMed - in process] Free Article

Related citations 16

Select item 24465426 34.

Glucopyranosyl Lipid A Adjuvant Significantly Enhances HIV Specific T and B Cell Responses Elicited by a DNA-MVA-Protein Vaccine Regimen.

McKay PF, Cope AV, Mann JF, Joseph S, Esteban M, Tatoud R, Carter D, Reed SG, Weber J, Shattock RJ.

PLoS One. 2014 Jan 23;9(1):e84707. doi: 10.1371/journal.pone.0084707. eCollection 2014 Jan 23.

PMID: 24465426 [PubMed - in process] Free Article

Related citations

Select item 24465412 35.

Immune Response Elicited by DNA Vaccination Using Lactococcus lactis Is Modified by the Production of Surface Exposed Pathogenic Protein.

Pontes D, Azevedo M, Innocentin S, Blugeon S, Lefévre F, Azevedo V, Miyoshi A, Courtin P, Chapot-Chartier MP, Langella P, Chatel JM.

PLoS One. 2014 Jan 21;9(1):e84509. doi: 10.1371/journal.pone.0084509. eCollection 2014 Jan 21.

PMID: 24465412 [PubMed - in process] Free Article

Related citations

Select item 24465365 36.

Nasopharyngeal Carriage and Transmission of Streptococcus pneumoniae in American Indian Households after a Decade of Pneumococcal Conjugate Vaccine Use.

Mosser JF, Grant LR, Millar EV, Weatherholtz RC, Jackson DM, Beall B, Craig MJ, Reid R, Santosham M, O'Brien KL.

PLoS One. 2014 Jan 17;9(1):e79578. doi: 10.1371/journal.pone.0079578. eCollection 2014 Jan 17.

PMID: 24465365 [PubMed - in process] Free Article

17

Related citations

Select item 24465269 37.

An Attenuated CMV Vaccine with a Deletion in Tegument Protein GP83 (pp65 Homolog) Protects against Placental Infection and Improves Pregnancy Outcome in a Guinea Pig Challenge Model.

Schleiss MR, Buus R, Choi KY, McGregor A.

Future Virol. 2013 Dec 1;8(12):1151-1160.

PMID: 24465269 [PubMed]

Related citations

Select item 24465206 38.

Intranasal Vaccination Promotes Detrimental Th17-Mediated Immunity against Influenza Infection.

Maroof A, Yorgensen YM, Li Y, Evans JT.

PLoS Pathog. 2014 Jan;10(1):e1003875. doi: 10.1371/journal.ppat.1003875. Epub 2014 Jan 23.

PMID: 24465206 [PubMed - in process] Free Article

Related citations

Select item 24465019 39.

European Public Health News * President's column: the future of vaccines in Europe * EUPHA office column * Message from the Regional Director: public health aspects of migration * Message from the EU Commissioner: doctors and pharmacists remain our best allies in the fight against antimicrobial resistance * Seventh European Public Health Conference--'Mind the Gap: reducing inequalities in health and health care'.

Paget DZ, Ricciardi W, Paget DZ, Jakab Z, Borg T.

Eur J Public Health. 2014 Feb;24(1):176-7. doi: 10.1093/eurpub/ckt211. No abstract available.

PMID: 24465019 [PubMed - in process] Free Article 18

Related citations

Select item 24464588 40.

Erratum to: Recent observations on site reactions in cattle to vaccination against contagious bovine pleuropneumonia (CBPP) using T1/44 vaccine in Zambia.

Muuka GM, Chikampa W, Mundia C, Buonavoglia D, Pini A, Scacchia M.

Trop Anim Health Prod. 2014 Jan 25. [Epub ahead of print] No abstract available.

PMID: 24464588 [PubMed - as supplied by publisher]

Related citations

Select item 24464586 41.

Influenza vaccine and survival in acute heart failure.

Kopel E, Klempfner R, Goldenberg I.

Eur J Heart Fail. 2013 Dec 6. doi: 10.1002/ejhf.14. [Epub ahead of print]

PMID: 24464586 [PubMed - as supplied by publisher]

Related citations

Select item 24464422 42.

Vaccine therapies for chronic hepatitis B: can we go further?

Wen Y, Wang X, Wang B, Yuan Z.

Front Med. 2014 Jan 24. [Epub ahead of print]

PMID: 24464422 [PubMed - as supplied by publisher]

Related citations

Select item 24464325 43.

Endorsement of Compulsory HIV Vaccination Policy Among Populations at High Risk of HIV Exposure (LA VOICES).

19

Newman PA, Lee SJ, Rudy ET, Diamant A, Duan N, Nakazano T, Cunningham WE.

Prev Sci. 2014 Jan 25. [Epub ahead of print]

PMID: 24464325 [PubMed - as supplied by publisher]

Related citations

Select item 24464109 44.

The case for flu vaccination for health professionals.

Aziz AM.

Br J Nurs. 2014 Jan 23;23(2):74-Unknown.

PMID: 24464109 [PubMed - in process]

Related citations

Select item 24463992 45.

FPL-vaccinated cats are protected from CPV2c and CPV2b challenge.

Jack SC, Sutton D, Bhogle A, Spibey N, Francis M.

Vet Rec. 2014 Jan 24. doi: 10.1136/vr.102037. [Epub ahead of print] No abstract available.

PMID: 24463992 [PubMed - as supplied by publisher]

Related citations

Select item 24463951 46.

Delay and Refusal of Human Papillomavirus Vaccine for Girls, National Immunization Survey-Teen, 2010.

Dorell C, Yankey D, Jeyarajah J, Stokley S, Fisher A, Markowitz L, Smith PJ.

Clin Pediatr (Phila). 2014 Jan 24. [Epub ahead of print]

PMID: 24463951 [PubMed - as supplied by publisher]

20

Related citations

Select item 24463806 47.

Trends in Asymptomatic Nasopharyngeal Colonization with Streptococcus pneumoniae After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Calgary, Canada.

Ricketson LJ, Wood ML, Vanderkooi OG, Macdonald JC, Martin IE, Demczuk WH, Kellner JD; for the Calgary Streptococcus pneumoniae Epidemiology Research (CASPER) investigators.

Pediatr Infect Dis J. 2014 Jan 23. [Epub ahead of print]

PMID: 24463806 [PubMed - as supplied by publisher]

Related citations

Select item 24463801 48.

Prevalence of Hepatitis B Vaccination among Health Care Workers in Nigeria in 2011- 12.

Ogoina D, Pondei K, Adetunji B, Chima G, Isichei C, Gidado S.

Int J Occup Environ Med. 2014 Jan;5(1):51-6.

PMID: 24463801 [PubMed - in process] Free Article

Related citations

Select item 24463269 49.

Immunomodulatory properties of the vaccine adjuvant alum.

Oleszycka E, Lavelle EC.

Curr Opin Immunol. 2014 Jan 22;28C:1-5. doi: 10.1016/j.coi.2013.12.007. [Epub ahead of print]

PMID: 24463269 [PubMed - as supplied by publisher]

Related citations

21

Select item 24463109 50.

[Foxp3(+)Treg cells mediate immune protection of humulus pollen allergy DNA vaccine pcDNA3.1-Hum in asthmatic mice].

Lu JM, Li MX, Sun XZ, Zhang YH, Liu Y, Xu J, Zhang SM.

Nan Fang Yi Ke Da Xue Xue Bao. 2014 Jan 20;34(1):14-9. Chinese.

PMID: 24463109 [PubMed - in process] Free Article

Related citations

Select item 24462961 51.

New advances in mucosal vaccination.

Ranasinghe C.

Immunol Lett. 2014 Jan 21. pii: S0165-2478(14)00010-8. doi: 10.1016/j.imlet.2014.01.006. [Epub ahead of print]

PMID: 24462961 [PubMed - as supplied by publisher]

Related citations

Select item 24462908 52.

Therapeutic Vaccines Against Hepatitis C Virus.

Xue J, Zhu H, Chen Z.

Infect Genet Evol. 2014 Jan 23. pii: S1567-1348(14)00011-2. doi: 10.1016/j.meegid.2014.01.008. [Epub ahead of print]

PMID: 24462908 [PubMed - as supplied by publisher]

Related citations

Select item 24462906 53.

22

Limited genetic diversity and purifying selection in Iranian Plasmodium falciparum Generative Cell Specific 1 (PfGCS1), a potential target for transmission-blocking vaccine.

Mehrizi AA, Zakeri S, Djadid ND.

Infect Genet Evol. 2014 Jan 23. pii: S1567-1348(14)00019-7. doi: 10.1016/j.meegid.2014.01.016. [Epub ahead of print]

PMID: 24462906 [PubMed - as supplied by publisher]

Related citations

Select item 24462900 54.

Polyplex-releasing microneedles for enhanced cutaneous delivery of DNA vaccine.

Kim NW, Lee MS, Kim KR, Lee JE, Lee K, Park JS, Matsumoto Y, Jo DG, Lee H, Lee DS, Jeong JH.

J Control Release. 2014 Jan 23. pii: S0168-3659(14)00045-5. doi: 10.1016/j.jconrel.2014.01.016. [Epub ahead of print]

PMID: 24462900 [PubMed - as supplied by publisher]

Related citations

Select item 24462846 55.

Evaluation of the thermal stability of a novel strain of live-attenuated mumps vaccine (RS-12 strain) lyophilized in different stabilizers.

Jamil RK, Taqavian M, Sadigh ZA, Shahkarami MK, Esna-Ashari F, Hamkar R, Hosseini SM, Hatami A.

J Virol Methods. 2014 Jan 22. pii: S0166-0934(13)00522-3. doi: 10.1016/j.jviromet.2013.12.020. [Epub ahead of print]

PMID: 24462846 [PubMed - as supplied by publisher]

Related citations

Select item 24462845 56.

Development of an assay to differentiate between virulent and vaccine strains of Lumpy Skin Disease virus (LSDV). 23

Menasherow S, Rubinstein-Giuni M, Kovtunenko A, Eyngor Y, Fridgut O, Rotenberg D, Khinich Y, Stram Y.

J Virol Methods. 2014 Jan 22. pii: S0166-0934(13)00515-6. doi: 10.1016/j.jviromet.2013.12.013. [Epub ahead of print]

PMID: 24462845 [PubMed - as supplied by publisher]

Related citations

Select item 24462800 57.

Hapten-specific naïve B cells are biomarkers of vaccine efficacy against drugs of abuse.

Taylor JJ, Laudenbach M, Tucker AM, Jenkins MK, Pravetoni M.

J Immunol Methods. 2014 Jan 23. pii: S0022-1759(14)00020-9. doi: 10.1016/j.jim.2014.01.010. [Epub ahead of print]

PMID: 24462800 [PubMed - as supplied by publisher]

Related citations

Select item 24462695 58.

Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease.

Kwon YM, Hwang HS, Lee JS, Ko EJ, Yoo SE, Kim MC, Lee YN, Kim KH, Song JM, Lee S, Moore ML, Kang SM.

Antiviral Res. 2014 Jan 23. pii: S0166-3542(14)00020-5. doi: 10.1016/j.antiviral.2014.01.008. [Epub ahead of print]

PMID: 24462695 [PubMed - as supplied by publisher]

Related citations

Select item 24462482 59.

Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.

Weingartl HM, Nfon CK, Zhang S, Marszal P, Wilson WC, Morrill JC, Bettinger GE, Peters CJ. 24

Vaccine. 2014 Jan 23. pii: S0264-410X(13)01815-X. doi: 10.1016/j.vaccine.2013.12.064. [Epub ahead of print]

PMID: 24462482 [PubMed - as supplied by publisher]

Related citations

Select item 24462481 60.

Vaccination with a HSV-2 UL24 mutant induces a protective immune response in murine and guinea pig vaginal infection models.

Visalli RJ, Natuk RJ, Kowalski J, Guo M, Blakeney S, Gangolli S, Cooper D.

Vaccine. 2014 Jan 23. pii: S0264-410X(13)01486-2. doi: 10.1016/j.vaccine.2013.10.079. [Epub ahead of print]

PMID: 24462481 [PubMed - as supplied by publisher]

Related citations

Select item 24462433 61.

Self-reported histories of disease and vaccination against measles, mumps, rubella and varicella in health care personnel in Japan.

Kumakura S, Onoda K, Hirose M.

J Infect Chemother. 2013 Dec 11. pii: S1341-321X(13)00045-7. doi: 10.1016/j.jiac.2013.10.006. [Epub ahead of print]

PMID: 24462433 [PubMed - as supplied by publisher]

Related citations

Select item 24462422 62.

Seroprevalence of tetanus toxoid antibody and booster vaccination efficacy in Japanese travelers.

Mizuno Y, Yamamoto A, Komiya T, Takeshita N, Takahashi M.

J Infect Chemother. 2013 Dec 11. pii: S1341-321X(13)00028-7. doi: 10.1016/j.jiac.2013.11.003. [Epub ahead of print]

25

PMID: 24462422 [PubMed - as supplied by publisher]

Related citations

Select item 24462406 63.

Demographic, socio-economic and geographic determinants of seasonal influenza vaccine uptake in rural western Kenya, 2011.

Otieno NA, Nyawanda BO, Audi A, Emukule G, Lebo E, Bigogo G, Ochola R, Muthoka P, Widdowson MA, Shay DK, Burton DC, Breiman RF, Katz MA, Mott JA.

Vaccine. 2014 Jan 22. pii: S0264-410X(13)01498-9. doi: 10.1016/j.vaccine.2013.10.089. [Epub ahead of print]

PMID: 24462406 [PubMed - as supplied by publisher]

Related citations

Select item 24462405 64.

Vaccination with Leishmania mexicana LPG induces PD-1 in CD8+ and PD-L2 in macrophages thereby suppressing the immune response: A model to assess vaccine efficacy.

Salazar MB, Domínguez JD, Estrada JS, Bonilla CG, Becker I.

Vaccine. 2014 Jan 22. pii: S0264-410X(14)00025-5. doi: 10.1016/j.vaccine.2014.01.016. [Epub ahead of print]

PMID: 24462405 [PubMed - as supplied by publisher]

Related citations

Select item 24462403 65.

Quantification by LC-MSE of outer membrane vesicle proteins of the Bexsero® vaccine.

Tani C, Stella M, Donnarumma D, Biagini M, Parente P, Vadi A, Magagnoli C, Costantino P, Rigat F, Norais N.

Vaccine. 2014 Jan 22. pii: S0264-410X(14)00012-7. doi: 10.1016/j.vaccine.2014.01.011. [Epub ahead of print]

PMID: 26

24462403 [PubMed - as supplied by publisher]

Related citations

Select item 24461913 66.

Vaccination with recombinant adenoviruses expressing Ebola virus glycoprotein elicits protection in the interferon alpha/beta receptor knock-out mouse.

O'Brien LM, Stokes MG, Lonsdale SG, Maslowski DR, Smither SJ, Lever MS, Laws TR, Perkins SD.

Virology. 2014 Jan 24. pii: S0042-6822(13)00181-5. doi: 10.1016/j.virol.2013.03.028. [Epub ahead of print]

PMID: 24461913 [PubMed - as supplied by publisher]

Related citations

Select item 24461526 67.

Enhancement of vitamin A combined vitamin D supplementation on immune response to Bacille Calmette-Guérin vaccine revaccinated in Chinese infants.

Zheng Y, Li XG, Wang QZ, Ma AG, Bygbjerg IC, Sun YY, Li Y, Zheng MC, Wang X.

Asian Pac J Trop Med. 2014 Feb;7(2):130-5. doi: 10.1016/S1995-7645(14)60008-0.

PMID: 24461526 [PubMed - in process]

Related citations

Select item 24461461 68.

Impact of 13-valent pneumococcal conjugate vaccine on otitis media bacteriology.

Zhao AS, Boyle S, Butrymowicz A, Engle RD, Roberts JM, Mouzakes J.

Int J Pediatr Otorhinolaryngol. 2014 Jan 5. pii: S0165-5876(13)00674-5. doi: 10.1016/j.ijporl.2013.12.028. [Epub ahead of print]

PMID: 24461461 [PubMed - as supplied by publisher]

Related citations

27

Select item 24461316 69.

Vitamin E, vitamin A, and zinc status are not related to serologic response to influenza vaccine in older adults: an observational prospective cohort study.

Sundaram ME, Meydani SN, Vandermause M, Shay DK, Coleman LA.

Nutr Res. 2014 Feb;34(2):149-54. doi: 10.1016/j.nutres.2013.12.004. Epub 2013 Dec 18.

PMID: 24461316 [PubMed - in process]

Related citations

Select item 24461201 70.

Evaluation of long-term antibody responses to two inactivated bovine viral diarrhoea virus (BVDV) vaccines.

González AM, Arnaiz I, Yus E, Eiras C, Sanjuán M, Diéguez FJ.

Vet J. 2013 Dec 11. pii: S1090-0233(13)00625-4. doi: 10.1016/j.tvjl.2013.12.005. [Epub ahead of print]

PMID: 24461201 [PubMed - as supplied by publisher]

Related citations

Select item 24461003 71.

Evaluation of peptide selection approaches for epitope-based vaccine design.

Schubert B, Lund O, Nielsen M.

Tissue Antigens. 2013 Oct;82(4):243-51. doi: 10.1111/tan.12199.

PMID: 24461003 [PubMed - in process]

Related citations

Select item 24460910 72.

Hexavalent vaccines for immunization in paediatric age.

28

Esposito S, Tagliabue C, Bosis S, Ierardi V, Gambino M, Principi N.

Clin Microbiol Infect. 2013 Dec 19. doi: 10.1111/1469-0691.12444. [Epub ahead of print]

PMID: 24460910 [PubMed - as supplied by publisher]

Related citations

Select item 24460679 73.

Not the right time: why parents refuse to let their daughters have the human papillomavirus vaccination.

Grandahl M, Oscarsson M, Stenhammar C, Nevéus T, Westerling R, Tydén T.

Acta Paediatr. 2013 Dec 19. doi: 10.1111/apa.12545. [Epub ahead of print]

PMID: 24460679 [PubMed - as supplied by publisher]

Related citations

Select item 24460305 74.

HPV Vaccine Knowledge and Perceived Risk of Cervical Cancer among Female College Students in Taiwan.

Wang HH, Wu SY.

Asian Pac J Cancer Prev. 2013;14(12):7371-4.

PMID: 24460305 [PubMed - in process] Free Article

Related citations

Select item 24459985 75.

[The application of recombinant Bacillus Calmette-Guérin vaccine and its vector in infectious disease].

Zulpiya T, Ding J.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2013 Oct;30(5):1136-40. Chinese.

29

PMID: 24459985 [PubMed - in process]

Related citations

Select item 24459978 76.

[Construction and eukaryotic expression of PVAX1-hPV58mE6E7fcGB composite gene vaccine].

Wang H, Yu J, Li L.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2013 Oct;30(5):1102-7. Chinese.

PMID: 24459978 [PubMed - in process]

Related citations

Select item 24459292 77.

The Bradford-Hill criteria and evidence of association between influenza vaccination and ischaemic heart disease.

Macintyre CR, Heywood AE.

Heart. 2014 Jan 23. doi: 10.1136/heartjnl-2013-305435. [Epub ahead of print] No abstract available.

PMID: 24459292 [PubMed - as supplied by publisher]

Related citations

Select item 24459191 78.

Intestinal Immunity Is a Determinant of Clearance of Poliovirus After Oral Vaccination.

Wright PF, Wieland-Alter W, Ilyushina NA, Hoen AG, Arita M, Boesch AW, Ackerman ME, van der Avoort H, Steven Oberste M, Pallansch MA, Burton AH, Jaffar MA, Sutter RW.

J Infect Dis. 2014 Jan 23. [Epub ahead of print]

PMID: 24459191 [PubMed - as supplied by publisher]

30

Related citations

Select item 24458207 79.

[Evaluation of a novel flu vaccination campaign among health personnel for the 2011- 2012 season].

Camargo-Ángeles R, Villanueva-Ruiz CO, García-Román V, Mendoza-García JL, Conesa- Peñuela FJ, Tenza Iglesias I, García Shimizu P, Sánchez-Payá J.

Arch Prev Riesgos Labor. 2014 Jan-Mar;17(1):26-30. doi: 10.12961/aprl.2014.17.1.04. Spanish.

PMID: 24458207 [PubMed - in process]

Related citations

Select item 24458025 80.

Evaluation of protective efficacy of the synthetic peptide vaccine containing the T helper 1 epitope with CpG oligodeoxynucleotide against feline infectious peritonitis virus infection in cats.

Takano T, Tomizawa K, Morioka H, Doki T, Hohdatsu T.

Antivir Ther. 2014 Jan 23. doi: 10.3851/IMP2735. [Epub ahead of print]

PMID: 24458025 [PubMed - as supplied by publisher]

Related citations

Select item 24457866 81.

Transient facial nerve paralysis (Bell's palsy) following administration of hepatitis B recombinant vaccine: a case report.

Paul R, Stassen LF.

Br Dent J. 2014 Jan 23;216(2):69-71. doi: 10.1038/sj.bdj.2014.1.

PMID: 24457866 [PubMed - in process]

Related citations

31

Select item 24457195 82.

Consistency of Bordetella pertussis vaccine seed strains and potency of whole-cell pertussis vaccine still in use in Poland.

Zawadka M, Mosiej E, Polak M, Krysztopa-Grzybowska K, Moskała B, Rokosz-Chudziak N, Rabczenko D, Augustynowicz E, Lutyńska A.

Biologicals. 2014 Jan 20. pii: S1045-1056(13)00138-3. doi: 10.1016/j.biologicals.2013.11.006. [Epub ahead of print]

PMID: 24457195 [PubMed - as supplied by publisher]

Related citations

Select item 24456962 83.

Herpes zoster in a 2-year-old vaccinated against varicella.

Ulman CA, Trevino JJ, Gandhi RK.

Dermatol Online J. 2014 Jan 15;20(1):21259.

PMID: 24456962 [PubMed - in process]

Related citations

Select item 24456625 84.

Yellow fever vaccine-associated adverse events following extensive immunization in .

Biscayart C, Carrega ME, Sagradini S, Gentile A, Stecher D, Orduna T, Bentancourt S, Jiménez SG, Flynn LP, Arce GP, Uboldi MA, Bugna L, Morales MA, Digilio C, Fabbri C, Enría D, Diosque M, Vizzotti C.

Vaccine. 2014 Jan 20. pii: S0264-410X(14)00024-3. doi: 10.1016/j.vaccine.2014.01.015. [Epub ahead of print]

PMID: 24456625 [PubMed - as supplied by publisher]

Related citations

Select item 24456444 85.

32

Knowledge of and attitude towards human papillomavirus infection and vaccines among nurses at a tertiary hospital in South Africa.

Hoque ME, Monokoane S, Van Hal G.

J Obstet Gynaecol. 2014 Feb;34(2):182-6. doi: 10.3109/01443615.2013.861395.

PMID: 24456444 [PubMed - in process]

Related citations

Select item 24456101 86.

Melanoma-associated antigen-A3 vaccination in the treatment of non-small-cell lung cancer.

Adam V, Wauters I, Vansteenkiste J.

Expert Opin Biol Ther. 2014 Jan 24. [Epub ahead of print]

PMID: 24456101 [PubMed - as supplied by publisher]

Related citations

Select item 24455862 87.

[Effect of surface-active substances of Acinetobacter calcoaceticus IMV B-7241, Rhodococcus erythropolis IMV Ac-5017, and Nocardia vaccinii K-8 on phytopathogenic bacteria].

[No authors listed]

Prikl Biokhim Mikrobiol. 2013 Jul-Aug;49(4):364-71. Russian.

PMID: 24455862 [PubMed - in process]

Related citations

Select item 24455752 88.

Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer.

Binder DC, Engels B, Arina A, Yu P, Slauch JM, Fu YX, Karrison T, Burnette B, Idel C, Zhao M, Hoffman RM, Munn DH, Rowley DA, Schreiber H.

33

Cancer Immunol Res. 2013 Aug;1:123-133.

PMID: 24455752 [PubMed]

Related citations

Select item 24455625 89.

Does HPV vaccination prevent cervical cancer?

Miller AB.

South Asian J Cancer. 2013 Oct;2(4):198-9. doi: 10.4103/2278-330X.119894. No abstract available.

PMID: 24455625 [PubMed] Free PMC Article

Related citations

Select item 24455622 90.

Is human papillomavirus vaccination likely to be a useful strategy in India?

Gupta S, Kerkar RA, Dikshit R, Badwe RA.

South Asian J Cancer. 2013 Oct;2(4):193-7. doi: 10.4103/2278-330X.119887.

PMID: 24455622 [PubMed] Free PMC Article

Related citations

Select item 24455618 91.

Efficacy and safety of human papillomavirus vaccine for primary prevention of cervical cancer: A review of evidence from phase III trials and national programs.

Basu P, Banerjee D, Singh P, Bhattacharya C, Biswas J.

South Asian J Cancer. 2013 Oct;2(4):187-92. doi: 10.4103/2278-330X.119877.

PMID: 24455618 [PubMed]

34

Free PMC Article

Related citations

Select item 24455492 92.

Impact of pneumococcal vaccines use on invasive pneumococcal disease in Nunavik (Quebec) from 1997 to 2010.

Le Meur JB, Lefebvre B, Proulx JF, Déry S, Pépin J, De Wals P.

Int J Circumpolar Health. 2014 Jan 17;73. doi: 10.3402/ijch.v73.22691. eCollection 2014 Jan 17.

PMID: 24455492 [PubMed - in process] Free PMC Article

Related citations

Select item 24455487 93.

Comparison of antibody responses to human papillomavirus vaccination as measured by three assays.

Robbins HA, Kemp TJ, Porras C, Rodriguez AC, Schiffman M, Wacholder S, Gonzalez P, Schiller J, Lowy D, Poncelet S, Esser M, Matys K, Hildesheim A, Pinto LA, Herrero R, Safaeian M.

Front Oncol. 2014 Jan 13;3:328. doi: 10.3389/fonc.2013.00328. eCollection 2014 Jan 13.

PMID: 24455487 [PubMed] Free PMC Article

Related citations

Select item 24454714 94.

Age-Dependent Association among Helicobacter pylori Infection, Serum Pepsinogen Levels and Immune Response of Children to Live Oral Cholera Vaccine CVD 103-HgR.

Muhsen K, Lagos R, Reymann MK, Graham DY, Pasetti MF, Levine MM.

PLoS One. 2014 Jan 15;9(1):e83999. doi: 10.1371/journal.pone.0083999. eCollection 2014 Jan 15.

PMID: 24454714 35

[PubMed - in process] Free PMC Article

Related citations

Select item 24454706 95.

Potential cost-effectiveness of a new infant tuberculosis vaccine in South Africa - implications for clinical trials: a decision analysis.

Ditkowsky JB, Schwartzman K.

PLoS One. 2014 Jan 15;9(1):e83526. doi: 10.1371/journal.pone.0083526. eCollection 2014 Jan 15.

PMID: 24454706 [PubMed - in process] Free PMC Article

Related citations

Select item 24454591 96.

A neonatal oral Mycobacterium tuberculosis-SIV prime / intramuscular MVA- SIV boost combination vaccine induces both SIV and Mtb-specific immune responses in infant macaques.

Jensen K, Pena MG, Wilson RL, Ranganathan UD, Jacobs WR Jr, Fennelly G, Larsen M, Van Rompay KK, Kozlowski PA, Abel K.

Trials Vaccinol. 2013 Nov 1;2:53-63.

PMID: 24454591 [PubMed]

Related citations

Select item 24454475 97.

B Epitope Multiplicity and B/T Epitope Orientation Influence Immunogenicity of Foot- and-Mouth Disease Peptide Vaccines.

Blanco E, Cubillos C, Moreno N, Bárcena J, de la Torre BG, Andreu D, Sobrino F.

Clin Dev Immunol. 2013;2013:475960. doi: 10.1155/2013/475960. Epub 2013 Dec 3.

PMID: 24454475 [PubMed - in process] Free PMC Article 36

Related citations

Select item 24454443 98.

Effect of zinc on humoral and cell-mediated immunity of broilers vaccinated against coccidiosis.

Sajadifar S, Miranzadeh H, Moazeni M.

Iran J Parasitol. 2013 Jul;8(3):474-80.

PMID: 24454443 [PubMed] Free PMC Article

Related citations

Select item 24454003 99.

Immunogenicity of influenza vaccine in colorectal cancer patients.

Kim DH, Lee YY, Shin US, Moon SM.

Cancer Res Treat. 2013 Dec;45(4):303-12. doi: 10.4143/crt.2013.45.4.303. Epub 2013 Dec 31.

PMID: 24454003 [PubMed] Free PMC Article

Related citations

Select item 24453366 100.

Novel Vaccine Regimen Elicits Strong Airway Immune Responses and Control of Respiratory Syncytial Virus in Non-Human Primates.

Grunwald T, Tenbusch M, Schulte R, Raue K, Wolf H, Hannaman D, de Swart RL, Uberla K, Stahl-Hennig C.

J Virol. 2014 Jan 22. [Epub ahead of print]

PMID: 24453366 [PubMed - as supplied by publisher]

Related citations

37

Select item 24453125 101.

Transcriptional profiling of recall responses to Francisella live vaccine strain.

Paranavitana C, Dasilva L, Vladimirova A, Pittman PR, Velauthapillai M, Nikolich M.

Pathog Dis. 2013 Nov 19. doi: 10.1111/2049-632X.12113. [Epub ahead of print]

PMID: 24453125 [PubMed - as supplied by publisher]

Related citations

Select item 24453061 102.

Yellow fever vaccine for patients with HIV infection.

Barte H, Horvath TH, Rutherford GW.

Cochrane Database Syst Rev. 2014 Jan 23;1:CD010929. [Epub ahead of print]

PMID: 24453061 [PubMed - as supplied by publisher]

Related citations

Select item 24452731 103.

Durability of response to vaccination against viral hepatitis A in HIV-infected patients: a 5-year observation.

Jablonowska E, Kuydowicz J.

Int J STD AIDS. 2014 Jan 22. [Epub ahead of print]

PMID: 24452731 [PubMed - as supplied by publisher]

Related citations

Select item 24452561 104.

Effectiveness of the trivalent influenza vaccine.

Kolber MR, Lau D, Eurich D, Korownyk C.

Can Fam Physician. 2014 Jan;60(1):50. No abstract available. 38

PMID: 24452561 [PubMed - in process] Free Article

Related citations

Select item 24452542 105.

The two faces of vaccine-induced immune response: protection or increased risk of HIV infection?!

Temchura V, Tenbusch M.

Virol Sin. 2014 Feb;29(1):7-9. doi: 10.1007/s12250-014-3419-9. No abstract available.

PMID: 24452542 [PubMed - in process]

Related citations

Select item 24452539 106.

New therapeutic vaccination strategies for the treatment of chronic hepatitis B.

Liu J, Kosinska A, Lu M, Roggendorf M.

Virol Sin. 2014 Feb;29(1):10-6. doi: 10.1007/s12250-014-3410-5. Epub 2014 Jan 17.

PMID: 24452539 [PubMed - in process]

Related citations

Select item 24451374 107.

Vaccinia Viral Protein A27 is Anchored to the Viral Membrane via a Cooperative Interaction with Viral Membrane Protein A17.

Wang DR, Hsiao JC, Wong CH, Li GC, Lin SC, Yu SS, Chen W, Chang W, Tzou DL.

J Biol Chem. 2014 Jan 22. [Epub ahead of print]

PMID: 24451374 [PubMed - as supplied by publisher] Free Article

39

Related citations

Select item 24451331 108.

Inclusion of the bovine neutrophil beta-defensin 3 with glycoprotein D of Bovine herpesvirus-1 in a DNA vaccine modulates immune responses of mice and cattle.

Mackenzie-Dyck S, Kovacs-Nolan J, Snider M, Babiuk LA, van Drunen Littel-van den Hurk S.

Clin Vaccine Immunol. 2014 Jan 22. [Epub ahead of print]

PMID: 24451331 [PubMed - as supplied by publisher]

Related citations

Select item 24451329 109.

An attenuated duck plague virus vaccine induces both systemic and mucosal immune responses to protect ducks against virulent DPV infection.

Huang J, Jia R, Wang M, Shu B, Yu X, Zhu D, Chen S, Yin Z, Chen X, Cheng A.

Clin Vaccine Immunol. 2014 Jan 22. [Epub ahead of print]

PMID: 24451329 [PubMed - as supplied by publisher]

Related citations

Select item 24451328 110.

Flagellin-A TLR5 agonist as an adjuvant in chicken vaccines.

Gupta SK, Bajwa P, Deb R, Chellappa MM, Dey S.

Clin Vaccine Immunol. 2014 Jan 22. [Epub ahead of print]

PMID: 24451328 [PubMed - as supplied by publisher]

Related citations

Select item 24451327 111.

40

Purification, stability, and immunogenicity analyses of five bluetongue virus proteins for use in subunit DIVA vaccine development.

Anderson J, Bréard E, Lövgren Bengtsson K, Grönvik KO, Zientara S, Valarcher JF, Hägglund S.

Clin Vaccine Immunol. 2014 Jan 22. [Epub ahead of print]

PMID: 24451327 [PubMed - as supplied by publisher]

Related citations

Select item 24451168 112.

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER-2.

De Giovanni C, Nicoletti G, Quaglino E, Landuzzi L, Palladini A, Ianzano ML, Dall Ora M, Grosso V, Ranieri D, Laranga R, Croci S, Amici A, Penichet ML, Iezzi M, Cavallo F, Nanni P, Lollini PL.

Breast Cancer Res. 2014 Jan 23;16(1):R10. [Epub ahead of print]

PMID: 24451168 [PubMed - as supplied by publisher]

Related citations

Select item 24451100 113.

Changes in Streptococcus pneumoniae Serotypes in the Nasopharynx of Japanese Children after Inoculation with a Heptavalent Pneumococcal Conjugate Vaccine.

Ueno M, Ishii Y, Tateda K, Anahara Y, Ebata A, Iida M, Mizuno F, Inamura S, Takahata K, Suzuki Y, Chang B, Wada A, Sugita M, Tanaka T, Nishiwaki Y.

Jpn J Infect Dis. 2014;67(1):40-3.

PMID: 24451100 [PubMed - in process] Free Article

Related citations

Select item 24451002 114.

Will booster doses be required for serogroup B meningococcal vaccine?

41

McQuaid F, Snape MD.

Expert Rev Vaccines. 2014 Jan 23. [Epub ahead of print]

PMID: 24451002 [PubMed - as supplied by publisher]

Related citations

Select item 24450996 115.

The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study.

Rose MA, Damm O, Greiner W, Knuf M, Wutzler P, Liese JG, Krüger H, Wahn U, Schaberg T, Schwehm M, Kochmann TF, Eichner M.

BMC Infect Dis. 2014 Jan 22;14(1):40. [Epub ahead of print]

PMID: 24450996 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 24450951 116.

Universal vaccination with the quadrivalent HPV vaccine in Austria: Impact on virus circulation, public health and cost-effectiveness analysis.

Bresse X, Goergen C, Prager B, Joura E.

Expert Rev Pharmacoecon Outcomes Res. 2014 Jan 22. [Epub ahead of print]

PMID: 24450951 [PubMed - as supplied by publisher]

Related citations

Select item 24450869 117.

Vaccination with recombinant Brugia malayi cystatin proteins alters worm migration, homing and final niche selection following a subcutaneous challenge of Mongolian gerbils (Meriones unguiculatus) with B. malayi infective larvae.

Arumugam S, Zhan B, Abraham D, Ward D, Lustigman S, Klei TR.

Parasit Vectors. 2014 Jan 22;7(1):43. [Epub ahead of print]

42

PMID: 24450869 [PubMed - as supplied by publisher] Free Article

Related citations

Select item 24450840 118.

Novel approaches to tuberculosis prevention: DNA vaccines.

Rivas-Santiago B, Cervantes-Villagrana AR.

Scand J Infect Dis. 2014 Jan 23. [Epub ahead of print]

PMID: 24450840 [PubMed - as supplied by publisher]

Related citations

Select item 24450591 119.

Budget constraint and vaccine dosing: a mathematical modelling exercise.

Standaert BA, Curran D, Postma MJ.

Cost Eff Resour Alloc. 2014 Jan 22;12(1):3. doi: 10.1186/1478-7547-12-3.

PMID: 24450591 [PubMed] Free Article

Related citations

Select item 24450242 120.

Awareness of and factors influencing willingness to receive a tetanus-diphtheria toxoid booster vaccine among Thai adults.

Pandejpong D, Phisalprapa P.

Southeast Asian J Trop Med Public Health. 2013 Nov;44(6):1047-54.

PMID: 24450242 [PubMed - in process]

Related citations

43

Select item 24450132 121.

[Diagnosis treatment and prevention of infectious diseases. Topics: IV. Progress in understanding of VPD (vaccine preventable disease); 2. Recognition and progress of vaccine preventable diseases in adulthood].

Maruyama T.

Nihon Naika Gakkai Zasshi. 2013 Nov 10;102(11):2936-44. Japanese. No abstract available.

PMID: 24450132 [PubMed - in process]

Related citations

Select item 24450131 122.

[Diagnosis treatment and prevention of infectious diseases. Topics: IV. Progress in understanding of VPD (vaccine preventable diseases); 1. Recognition and progress of vaccine preventable diseases in childhood].

Saitoh A.

Nihon Naika Gakkai Zasshi. 2013 Nov 10;102(11):2928-35. Japanese. No abstract available.

PMID: 24450131 [PubMed - in process]

Related citations

Select item 24450046 123.

Comparison of oral and intramuscular recombinant canine distemper vaccination in African wild dogs (Lycaon pictus).

Connolly M, Thomas P, Woodroffe R, Raphael BL.

J Zoo Wildl Med. 2013 Dec;44(4):882-8.

PMID: 24450046 [PubMed - in process]

Related citations

Select item 24449960 124.

44

Improving pneumococcal and herpes zoster vaccination uptake: expanding pharmacist privileges.

Taitel MS, Fensterheim LE, Cannon AE, Cohen ES.

Am J Manag Care. 2013 Sep;19(9):e309-13.

PMID: 24449960 [PubMed - in process]

Related citations

AMEDEO - Vaccines Publicaciones (27 - 01 - 2014): 24 artículos nuevos.

Vacunas Meningococo (Neisseria meningitidis)

8. ELIAS J. Loosening the grip of meningococcal disease in Africa. Lancet. 2014;383:6-8. PubMed: www.amedeo.com/p2.php?id=24035221&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/24035221

Vacunas Neumococo (Streptococcus pneumoniae)

12. BECKER-DREPS S, Amaya E, Liu L, Moreno G, et al. Changes in Childhood Pneumonia and Infant Mortality Rates Following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Nicaragua. Pediatr Infect Dis J. 2014. PubMed: www.amedeo.com/p2.php?id=24445827&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24445827

21. LU CL, Chang SY, Chuang YC, Liu WC, et al. Revaccination with 7-valent pneumococcal conjugate vaccine elicits better serologic response than 23-valent pneumococcal polysaccharide vaccine in HIV-infected adult patients who have undergone primary vaccination with 23-valent pneumococcal polysaccharide vaccine in the era of combination antiretroviral therapy. Vaccine. 2014 Jan 15. pii: S0264-410X(14)00010. PubMed: www.amedeo.com/p2.php?id=24440112&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24440112

Vacunas Fiebre tifoidea (Salmonella typhi)

16. BHUIYAN TR, Choudhury FK, Khanam F, Saha A, et al. Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh. Vaccine. 2014 Jan 14. pii: S0264-410X(14)00002. PubMed: www.amedeo.com/p2.php?id=24440210&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24440210

Vacuna Tosferina (Bordetella pertussis)

5. SMALLRIDGE WE, Rolin OY, Jacobs NT, Harvill ET, et al. Different effects of whole cell and acellular vaccines on Bordetella 45 transmission. J Infect Dis. 2014. PubMed: www.amedeo.com/p2.php?id=24443545&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24443545

10. WOOD N, Marshall H, White OJ, Holt PG, et al. Antibody and Cell Mediated Immunity to Pertussis 4 Years after Monovalent Acellular Pertussis Vaccine at Birth. Pediatr Infect Dis J. 2014. PubMed: www.amedeo.com/p2.php?id=24445839&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24445839

Vacuna Tuberculosis (Mycobacterium tuberculosis)

14. RIVAS-SANTIAGO B, Cervantes-Villagrana AR. Novel approaches to tuberculosis prevention: DNA vaccines. Scand J Infect Dis. 2014. PubMed: www.amedeo.com/p2.php?id=24450840&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24450840

Vacunas, otras

1. MONTO AS, Ohmit SE. Reply to Sullivan and Kelly and Skowronski et al. Clin Infect Dis. 2013;57:477-8. PubMed: www.amedeo.com/p2.php?id=23619810&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/23619810

2. HEALY CM, Rench MA, Baker CJ. Reply to Leuridan et al. Clin Infect Dis. 2013;57:472-3. PubMed: www.amedeo.com/p2.php?id=23580734&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/23580734

3. GEETA MG, Riyaz A. Prevention of mother to child transmission of hepatitis B infection. Indian Pediatr. 2013;50:189-92. PubMed: www.amedeo.com/p2.php?id=23474924&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23474924

4. SKOWRONSKI DM, Janjua NZ, Sabaiduc S, De Serres G, et al. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-12 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. J Infect Dis. 2014. PubMed: www.amedeo.com/p2.php?id=24446529&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24446529

5. SMALLRIDGE WE, Rolin OY, Jacobs NT, Harvill ET, et al. Different effects of whole cell and acellular vaccines on Bordetella

46 transmission. J Infect Dis. 2014. PubMed: www.amedeo.com/p2.php?id=24443545&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24443545

6. GRUNWALD T, Tenbusch M, Schulte R, Raue K, et al. Novel Vaccine Regimen Elicits Strong Airway Immune Responses and Control of Respiratory Syncytial Virus in Non-Human Primates. J Virol. 2014. PubMed: www.amedeo.com/p2.php?id=24453366&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24453366

7. KUEHN BM. Public health officials mark 50th year of measles vaccine: concern remains about outbreaks in pockets of unvaccinated. JAMA. 2014;311:345-6. PubMed: www.amedeo.com/p2.php?id=24449296&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24449296

8. ELIAS J. Loosening the grip of meningococcal disease in Africa. Lancet. 2014;383:6-8. PubMed: www.amedeo.com/p2.php?id=24035221&s=vac&pm=badc2a9eebb0fad Share: http://m.amedeo.com/24035221

9. Rubella and congenital rubella syndrome control and elimination - global progress, 2000-2012. MMWR Morb Mortal Wkly Rep. 2013;62:983-6. PubMed: www.amedeo.com/p2.php?id=24304830&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24304830

10. WOOD N, Marshall H, White OJ, Holt PG, et al. Antibody and Cell Mediated Immunity to Pertussis 4 Years after Monovalent Acellular Pertussis Vaccine at Birth. Pediatr Infect Dis J. 2014. PubMed: www.amedeo.com/p2.php?id=24445839&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24445839

11. GREENBERG DP, Robertson CA, Landolfi VA, Bhaumik A, et al. Safety and Immunogenicity of an Inactivated Quadrivalent Influenza Vaccine in Children 6 Months through 8 Years of Age. Pediatr Infect Dis J. 2014. PubMed: www.amedeo.com/p2.php?id=24445833&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24445833

12. BECKER-DREPS S, Amaya E, Liu L, Moreno G, et al.

47

Changes in Childhood Pneumonia and Infant Mortality Rates Following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Nicaragua. Pediatr Infect Dis J. 2014. PubMed: www.amedeo.com/p2.php?id=24445827&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24445827

13. BAMBERGER EE, Ben-Shimol S, Abu Raya B, Katz A, et al. Pediatric Invasive Haemophilus influenzae Infections in Israel in the Era of Haemophilus influenzae type b Vaccine: A Nationwide Prospective Study. Pediatr Infect Dis J. 2014. PubMed: www.amedeo.com/p2.php?id=24445822&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24445822

14. RIVAS-SANTIAGO B, Cervantes-Villagrana AR. Novel approaches to tuberculosis prevention: DNA vaccines. Scand J Infect Dis. 2014. PubMed: www.amedeo.com/p2.php?id=24450840&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24450840

15. DALZIEL M, Crispin M, Scanlan CN, Zitzmann N, et al. Emerging principles for the therapeutic exploitation of glycosylation. Science. 2014;343:1235681. PubMed: www.amedeo.com/p2.php?id=24385630&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24385630

16. BHUIYAN TR, Choudhury FK, Khanam F, Saha A, et al. Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh. Vaccine. 2014 Jan 14. pii: S0264-410X(14)00002. PubMed: www.amedeo.com/p2.php?id=24440210&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24440210

17. LE MENACH A, Boxall N, Amirthalingam G, Maddock L, et al. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England. Vaccine. 2014 Jan 14. pii: S0264-410X(14)00003. PubMed: www.amedeo.com/p2.php?id=24440207&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24440207

18. CHERIF MS, Shuaibu MN, Kodama Y, Helegbe GK, et al. Nanoparticle formulation enhanced protective immunity provoked by PYGPI8p-transamidase related protein (PyTAM) DNA vaccine in Plasmodium yoelii malaria model. Vaccine. 2014 Jan 14. pii: S0264-410X(14)00006. PubMed: www.amedeo.com/p2.php?id=24440206&s=vac&pm=badc2a9eebb0fad ABSTRACT available

48

Share: http://m.amedeo.com/24440206

19. BISSETT SL, Draper E, Myers RE, Godi A, et al. Cross-neutralizing antibodies elicited by the Cervarix human papillomavirus vaccine display a range of Alpha-9 inter-type specificities. Vaccine. 2014 Jan 14. pii: S0264-410X(14)00009. PubMed: www.amedeo.com/p2.php?id=24440205&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24440205

20. WILSON K, Ducharme R, Ward B, Hawken S, et al. Increased emergency room visits or hospital admissions in females after 12-month MMR vaccination, but no difference after vaccinations given at a younger age. Vaccine. 2014 Jan 15. pii: S0264-410X(14)00011. PubMed: www.amedeo.com/p2.php?id=24440113&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24440113

21. LU CL, Chang SY, Chuang YC, Liu WC, et al. Revaccination with 7-valent pneumococcal conjugate vaccine elicits better serologic response than 23-valent pneumococcal polysaccharide vaccine in HIV-infected adult patients who have undergone primary vaccination with 23-valent pneumococcal polysaccharide vaccine in the era of combination antiretroviral therapy. Vaccine. 2014 Jan 15. pii: S0264-410X(14)00010. PubMed: www.amedeo.com/p2.php?id=24440112&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24440112

22. BROWN DS, Arnold SE, Asay G, Lorick SA, et al. Parent attitudes about school-located influenza vaccination clinics. Vaccine. 2014 Jan 15. pii: S0264-410X(14)00004. PubMed: www.amedeo.com/p2.php?id=24440111&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24440111

23. Progress towards poliomyelitis eradication in Nigeria, January 2012-September 2013. Wkly Epidemiol Rec. 2013;88. PubMed: www.amedeo.com/p2.php?id=24436996&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24436996

24. HAINING WN. Strength in numbers: comparing vaccine signatures the modular way. Nat Immunol. 2014;15:139-41. PubMed: www.amedeo.com/p2.php?id=24448573&s=vac&pm=badc2a9eebb0fad

Share: http://m.amedeo.com/24448573

49

PATENTES

United States Patent and Trademark Office (USPTO)

Estrategia de búsqueda “vaccine” en título y abstract

(ABST/vaccine AND ISD/20140121->20140131): 6 patentes recuperadas.

Vacunas, otras

PAT. Title NO.

1 8,637,307 Activation and expansion of T-cells using an engineered multivalent signaling platform as a

research tool

2 8,637,234 Molecular scaffolds for HIV-1 epitopes

3 8,637,047 Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same

4 8,637,043 Compositions useful as ligands for the formyl peptide

receptor like 1 receptor and methods of use thereof

5 8,637,025 Composition and method for the treatment and prevention of enteric bacterial infections

6 8,632,783 Compositions for immunising against Staphylococcus

aureus

50

European Patent Office (EPO)

Acumulado entre el 21 y el 31 de enero de 2014: 16 patentes recuperadas.

Vacunas Neumococo (Streptococcus pneumoniae)

14. VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES

Publication info: EP2687228 (A2) 2014-01-22

Vacunas Tuberculosis (Mycobacterium tuberculosis)

3. DENDRITIC CELLS (DCS) TARGETING FOR TUBERCULOSIS (TB) VACCINE

Publication info: EP2688591 (A1) 2014-01-29

Vacunas, otras

1. Process for preparing vaccine composition

GB2504444 (A) 2014-01-29 Publication info:

2. Method for generating dry vaccine powder formulation for intranasal delivery

EP2689785 (A1) 2014-01-29 Publication info:

3. DENDRITIC CELLS (DCS) TARGETING FOR TUBERCULOSIS (TB) VACCINE

EP2688591 (A1) 2014-01-29 Publication info:

4. METHOD OF SCREENING ANTIRETROVIRAL COMPOUNDS AND VACCINE

EP2688574 (A1) 2014-01-29 Publication info:

5. METHOD FOR THE PRODUCTION OF PROTEIN COMPLEXES AND VACCINE COMPOSITIONS COMPRISING THE SAME

EP2688589 (A1) 2014-01-29 Publication info:

6. SALMONID ALPHAVIRUS VACCINE

EP2688587 (A1) 2014-01-29 Publication info:

7. COMPOSITIONS, METHODS AND USES FOR POXVIRUS ELEMENTS IN VACCINE CONSTRUCTS AGAINST INFLUENZA VIRUS SUBTYPES OR STRAINS

51

WO2014015287 (A2) 2014-01-23 Publication info:

8. CANCER VACCINE COMPOSITION

US2014023670 (A1) 2014-01-23 Publication info:

9. Vaccine Against Pasteurellaceae

US2014023684 (A1) 2014-01-23 Publication info:

10. Nucleic Acid Molecule Encoding Hepatitis B Virus Core Protein And Vaccine Comprising The Same

US2014023613 (A1) 2014-01-23 Publication info:

11. NUCLEIC ACID MOLECULES ENCODING NOVEL HERPES ANTIGENS, VACCINE COMPRISING THE SAME, AND METHODS OF USE THEREOF

US2014023673 (A1) 2014-01-23 Publication info:

12. BIVALENT VACCINE FOR MARINE FISH AND METHOD FOR MAKING THE SAME

US2014023685 (A1) 2014-01-23 Publication info:

13. SYNTHETIC OLIGOSACCHARIDES FOR P. AERUGINOSA VACCINE

WO2014014670 (A1) 2014-01-23 Publication info:

14. VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES

EP2687228 (A2) 2014-01-22 Publication info:

15. Emulsified composition for dilution and cancer vaccine composition

EP2687203 (A1) 2014-01-22 Publication info:

16. Stabilizer and vaccine composition comprising one or more live attenuated flaviviruses

EP2687229 (A1) 2014-01-22 Publication info:

17. IPN Vaccine

EP2686011 (A2) 2014-01-22 Publication info:

18. EQUINE RHINITIS VACCINE

EP2686012 (A2) 2014-01-22 Publication info:

52

TABLAS DE CONTENIDO

Revista Vaccine

New Articles in Press, 20 January-26 January 2014.

1. Evaluation of Dengue Virus strains for human challenge studies Original Research Article

Available online 24 January 2014 M.P. Mammen, A. Lyons, B.L. Innis, W. Sun, D. McKinney, R.C.Y. Chung, K.H. Eckels, R. Putnak, N. Kanesa-thasan, J.M. Scherer, J. Statler, L.V. Asher, S.J. Thomas, D.W. Vaughn

2. Vaccination with a HSV-2 UL24 mutant induces a protective immune response in murine and guinea pig vaginal infection models Original Research Article

Available online 24 January 2014 Robert J. Visalli, Robert J. Natuk, Jacek Kowalski, Min Guo, Susan Blakeney, Seema Gangolli, David Cooper

3. Vaccination with Leishmania mexicana LPG induces PD-1 in CD8+ and PD-L2 in macrophages thereby suppressing the immune response: A model to assess vaccine efficacy Original Research Article

Available online 23 January 2014 M.B. Martínez Salazar, J. Delgado Domínguez, J. Silva Estrada, C. González Bonilla, I. Becker

4. Quantification by LC–MSE of outer membrane vesicle proteins of the Bexsero® vaccine Original Research Article

Available online 23 January 2014 Chiara Tani, Maria Stella, Danilo Donnarumma, Massimiliano Biagini, Pierino Parente, Alessandro Vadi, Claudia Magagnoli, Paolo Costantino, Fabio Rigat, Nathalie Norais

5. Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep Original Research Article

Available online 23 January 2014 Hana M. Weingartl, Charles K. Nfon, Shunzhen Zhang, Peter Marszal, William C. Wilson, John.C. Morrill, George E. Bettinger, Clarence J. Peters

6. Attenuated Mycoplasma bovis strains provide protection against virulent infection in calves Original Research Article

Available online 23 January 2014 Rui Zhang, Xiaoxiao Han, Yingyu Chen, Riaz Mustafa, Jingjing Qi, Xi Chen, Changmin Hu, Huanchun Chen, Aizhen Guo

53

7. Demographic, socio-economic and geographic determinants of seasonal influenza vaccine uptake in rural western Kenya, 2011 Original Research Article

Available online 22 January 2014 Nancy A. Otieno, Bryan O. Nyawanda, Allan Audi, Gideon Emukule, Emmaculate Lebo, Godfrey Bigogo, Rachel Ochola, Phillip Muthoka, Marc- Alain Widdowson, David K. Shay, Deron C. Burton, Robert F. Breiman, Mark A. Katz, Joshua A. Mott

8. Yellow fever vaccine-associated adverse events following extensive immunization in Argentina Original Research Article

Available online 21 January 2014 Cristián Biscayart, María Eugenia Pérez Carrega, Sandra Sagradini, Ángela Gentile, Daniel Stecher, Tomás Orduna, Silvia Bentancourt, Salvador García Jiménez, Luis Pedro Flynn, Gabriel Pirán Arce, María Andrea Uboldi, Laura Bugna, María Alejandra Morales, Clara Digilio, Cintia Fabbri, Delia Enría, Máximo Diosque, Carla Vizzotti

9. Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study Original Research Article

Available online 20 January 2014 Maria Luisa Iaria, Simona Fiorentini, Emanuele Focà, Sonia Zicari, Cinzia Giagulli, Francesca Caccuri, Daniela Francisci, Giovanni Di Perri, Francesco Castelli, Franco Baldelli, Arnaldo Caruso

Tabla de Contenidos. Volume 32, Issue 9, Pages 1029 - 1130 (19 February 2014).

1. Editorial Board/Aims and Scope

Pages CO2

Letter to the Editor

2. Vaccines at what price?

Pages 1029-1030 D.S. Stephens, R. Ahmed, W.A. Orenstein

Brief report

3. Revaccination with 7-valent pneumococcal conjugate vaccine elicits better serologic response than 23-valent pneumococcal polysaccharide vaccine in HIV-infected adult patients who have undergone primary vaccination with

54

23-valent pneumococcal polysaccharide vaccine in the era of combination antiretroviral therapy

Pages 1031-1035 Ching-Lan Lu, Sui-Yuan Chang, Yu-Chung Chuang, Wen-Chun Liu, Chin-Ting Su, Yi-Ching Su, Shu-Fang Chang, Chien-Ching Hung

Review

4. Budget process bottlenecks for immunization financing in the Democratic Republic of the Congo (DRC) Review Article

Pages 1036-1042 Jean-Bernard Le Gargasson, Benoît Mibulumukini, Bradford D. Gessner, Anaïs Colombini

Regular papers

5. Parent attitudes about school-located influenza vaccination clinics Original Research Article

Pages 1043-1048 Derek S. Brown, Sarah E. Arnold, Garrett Asay, Suchita A. Lorick, Bo-Hyun Cho, Ricardo Basurto-Davila, Mark L. Messonnier

6. Characterization of the structural modifications accompanying the loss of HBsAg particle immunogenicity Original Research Article

Pages 1049-1054 Vanille J. Greiner, Catherine Manin, Eric Larquet, Nabila Ikhelef, Frédéric Gréco, Sophie Naville, Pierre-Emmanuel Milhiet, Frédéric Ronzon, Andrey Klymchenko, Yves Mély

7. Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh Original Research Article

Pages 1055-1060 Taufiqur R. Bhuiyan, Feroza K. Choudhury, Farhana Khanam, Amit Saha, Md. Abu Sayeed, Umme Salma, Anna Lundgren, David A. Sack, Ann-Mari Svennerholm, Firdausi Qadri

8. Adverse events following immunization in Ontario's female school-based HPV program Original Research Article

Pages 1061-1066 Tara Harris, Dawn M. Williams, Jill Fediurek, Tsui Scott, Shelley L. Deeks

9. Trend in proportions of missed children during polio supplementary immunization activities in the African Region: Evidence from independent monitoring data 2010–2012 Original Research Article

55

Pages 1067-1071 Joseph Okeibunor, Alex Gasasira, Richard Mihigo, Mbaye Salla, Alain Poy, Godwin Orkeh, Keith Shaba, Deo Nshimirimana

10. Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study Original Research Article

Pages 1072-1078 Maria Luisa Iaria, Simona Fiorentini, Emanuele Focà, Sonia Zicari, Cinzia Giagulli, Francesca Caccuri, Daniela Francisci, Giovanni Di Perri, Francesco Castelli, Franco Baldelli, Arnaldo Caruso

11. Human papillomavirus infection among human immunodeficiency virus- infected women in Maharashtra, India Original Research Article

Pages 1079-1085 S. Joshi, J.M. Babu, D. Jayalakshmi, V. Kulkarni, U. Divate, R. Muwonge, T. Gheit, M. Tommasino, R. Sankaranarayanan, M.R. Pillai

12. Recombinant FAdV-4 fiber-2 protein protects chickens against hepatitis– hydropericardium syndrome (HHS) Original Research Article

Pages 1086-1092 Anna Schachner, Ana Marek, Barbara Jaskulska, Ivana Bilic, Michael Hess

13. Generation of a safety enhanced Salmonella Gallinarum ghost using antibiotic resistance free plasmid and its potential as an effective candidate against fowl typhoid Original Research Article

Pages 1093-1099 Chetan V. Jawale, Atul A. Chaudhari, John Hwa Lee

14. Dynamic profiles of neutralizing antibody responses elicited in rhesus monkeys immunized with a combined tetravalent DTaP-Sabin IPV candidate vaccine Original Research Article

Pages 1100-1106 Mingbo Sun, Yan Ma, Yinhua Xu, Huijuan Yang, Li Shi, Yanchun Che, Guoyang Liao, Shude Jiang, Shumin Zhang, Qihan Li

15. Attitudes, knowledge and perceptions towards whooping cough and pertussis vaccine in hospitalized adults Original Research Article

Pages 1107-1112 Iman Ridda, Zhanhai Gao, C Raina MacIntyre

16. Development of a whole cell pneumococcal vaccine: BPL inactivation, cGMP production, and stability Original Research Article

Pages 1113-1120

56

Viviane M. Gonçalves, Waldely O. Dias, Ivana B. Campos, Celia Liberman, Maria E. Sbrogio-Almeida, Eliane P. Silva, Celso P. Cardoso, Mark Alderson, George Robertson, Jean-François Maisonneuve, Andrea Tate, Porter Anderson, Richard Malley, Fernando Fratelli, Luciana C.C. Leite

17. An observer-blind, randomized, multi-center trial assessing long-term safety and immunogenicity of AS03-adjuvanted or unadjuvanted H1N1/2009 influenza vaccines in children 10–17 years of age Original Research Article

Pages 1121-1129 Airi Poder, Pavol Simurka, Ping Li, Sumita Roy-Ghanta, David Vaughn

Tabla de Contenidos. Volume 32, Issue 8, Pages 897 - 1028 (12 February 2014).

1. Editorial Board/Aims and Scope

Pages CO2

Brief reports

2. Decline of varicella vaccination in German surveillance regions after recommendation of separate first-dose vaccination for varicella and measles–mumps–rubella

Pages 897-900 Andrea Streng, Johannes G. Liese

3. Evaluation of the feasibility of a state-based vaccine safety advice network

Pages 901-903 S. Elizabeth Williams, Claudia Vellozzi, Kathryn M. Edwards, Kelly L. Moore, Devindra Sharma, Clarence B. Creech

Reviews

4. The introduction of new vaccines into developing countries. V: Will we lose a decade or more in the introduction of dengue vaccines to developing countries? Review Article

Pages 904-908 Richard Mahoney

5. Development of immunization trials against Pasteurella multocida Review Article

57

Pages 909-917 Tarek A. Ahmad, Samar S. Rammah, Salah A. Sheweita, Medhat Haroun, Laila H. El-Sayed

Regular papers

6. Immunotherapeutics to prevent the replication of Brucella in a treatment failure mouse model Original Research Article

Pages 918-923 N. Jain-Gupta, A. Contreras-Rodriguez, G.P. Smith, V.K. Garg, S.G. Witonsky, S. Isloor, R. Vemulapalli, S.M. Boyle, N. Sriranganathan

7. A cohort event monitoring to determine the adverse events following administration of mouse brain derived, inactivated Japanese Encephalitis vaccine in an endemic district in Sri Lanka Original Research Article

Pages 924-930 De Alwis K.N.L.S.K., Abeysinghe M.R.N., Wickramesinghe A.R., Wijesinghe P.R.

8. Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes Original Research Article

Pages 931-937 María Emilia Gaillard, Daniela Bottero, Agustina Errea, Maximiliano Ormazábal, M. Eugenia Zurita, Griselda Moreno, Martin Rumbo, Celina Castuma, Erika Bartel, Dario Flores, Peter van der Ley, Arno van der Ark, Daniela F. Hozbor

9. Efficient lysis of epithelial ovarian cancer cells by MAGE-A3-induced cytotoxic T lymphocytes using rAAV-6 capsid mutant vector Original Research Article

Pages 938-943 Ramesh B. Batchu, Oksana V. Gruzdyn, Amberly M. Moreno-Bost, Susann Szmania, Giridhararao Jayandharan, Arun Srivastava, Bala K. Kolli, Donald W. Weaver, Frits van Rhee, Scott A. Gruber

10. Estimation of the herd protection of Haemophilus influenzae type b conjugate vaccine against radiologically confirmed pneumonia in children under 2 years old in Dhaka, Bangladesh Original Research Article

Pages 944-948 Wei-Ju Chen, Lawrence H. Moulton, Samir K. Saha, Abdullah Al Mahmud, Shams El Arifeen, Abdullah H. Baqui

11. Recombinant chimeric Japanese encephalitis virus/tick-borne encephalitis virus is attenuated and protective in mice Original Research Article

Pages 949-956 Hong-Jiang Wang, Xiao-Feng Li, Qing Ye, Shi-Hua Li, Yong-Qiang Deng, Hui

58

Zhao, Yan-Peng Xu, Jie Ma, E-De Qin, Cheng-Feng Qin

12. Production of NY-ESO-1 peptide/DRB1*08:03 tetramers and ex vivo detection of CD4 T-cell responses in vaccinated cancer patients Original Research Article

Pages 957-964 Yu Mizote, Akiko Uenaka, Midori Isobe, Hisashi Wada, Kazuhiro Kakimi, Takashi Saika, Shoichi Kita, Yukari Koide, Mikio Oka, Eiichi Nakayama

13. Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: Results of an open-label, randomized, phase 3b controlled study in healthy infants Original Research Article

Pages 965-972 Arturo Abdelnour, Peter E. Silas, Marta Raquel Valdés Lamas, Carlos Fernándo Grazioso Aragón, Nan-Chang Chiu, Cheng-Hsun Chiu, Teobaldo Herrera Acuña, Tirza De León Castrejón, Allen Izu, Tatjana Odrljin, Igor Smolenov, Matthew Hohenboken, Peter M. Dull

Regular papers

14. Influenza associated mortality in Southern China, 2010–2012 Original Research Article

Pages 973-978 Hui Wang, Chuanxi Fu, Kuibiao Li, Jianyun Lu, Yiyun Chen, Enjie Lu, Xincai Xiao, Biao Di, Huazhang Liu, Zhicong Yang, Ming Wang

Regular papers

15. Incidence and variables associated with inadequate antibody titers after pre- exposure rabies vaccination among veterinary medical students Original Research Article

Pages 979-983 Namrata Banga, Paula Guss, Amit Banga, Kenneth D. Rosenman

Regular papers

16. Oral vaccination and protection of red foxes (Vulpes vulpes) against rabies using ONRAB®, an adenovirus-rabies recombinant vaccine Original Research Article

Pages 984-989 L.J. Brown, R.C. Rosatte, C. Fehlner-Gardiner, P. Bachmann, J.A. Ellison, F.R. Jackson, J.S. Taylor, C. Davies, D. Donovan

59

Regular papers

17. Pneumococcal vaccine targeting strategy for older adults: Customized risk profiling Original Research Article

Pages 990-995 Ran D. Balicer, Chandra J. Cohen, Morton Leibowitz, Becca S. Feldman, Ilan Brufman, Craig Roberts, Moshe Hoshen

Regular papers

18. The relationship between concentration of specific antibody at birth and subsequent response to primary immunization Original Research Article

Pages 996-1002 Christine Jones, Louisa Pollock, Sara M. Barnett, Anna Battersby, Beate Kampmann

Regular papers

19. Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor Original Research Article

Pages 1003-1011 Felipe Tapia, Thomas Vogel, Yvonne Genzel, Ilona Behrendt, Mark Hirschel, J. David Gangemi, Udo Reichl

Regular papers

20. Comparison of prophylactic and therapeutic immunisation with an ErbB-2 (HER2) fusion protein and immunoglobulin V-gene repertoire analysis in a transgenic mouse model of spontaneous breast cancer Original Research Article

Pages 1012-1018 Arunima Mukhopadhyay, Charlotte Dyring, David I. Stott

Regular papers

21. Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: A randomized trial Original Research Article

Pages 1019-1028 Jennifer G. Wright, Brian D. Plikaytis, Charles E. Rose, Scott D. Parker, Janiine

60

Babcock, Wendy Keitel, Hana El Sahly, Gregory A. Poland, Robert M. Jacobson, Harry L. Keyserling, Vera A. Semenova, Han Li, Jarad Schiffer, Hanan Dababneh, Sandra K. Martin, Stacey W. Martin, Nina Marano, Nancy E. Messonnier, Conrad P. Quinn

Tabla de Contenidos. Volume 32, Issue 7, Pages 755 -896 (7 February 2014).

1. Editorial Board/Aims and Scope

Pages CO2

Brief report

2. Characterization of Streptococcus pneumoniae invasive serotype 19A isolates recovered in Colombia

Pages 755-758 Viviana Ramos, Eliana L. Parra, Carolina Duarte, Jaime Moreno

Reviews

3. Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analyses Review Article

Pages 759-765 A.T. Newall, J.F. Reyes, J.G. Wood, P. McIntyre, R. Menzies, P. Beutels

4. Approved but non-funded vaccines: Accessing individual protection Review Article

Pages 766-770 David W. Scheifele, Brian J. Ward, Scott A. Halperin, Shelly A. McNeil, Natasha S. Crowcroft, Gordean Bjornson

Regular papers

5. Construction and evaluation of replication-defective recombinant optimized triosephosphate isomerase adenoviral vaccination in Schistosoma japonicum challenged mice Original Research Article

Pages 771-778 Yang Dai, Xiaoting Wang, Song Zhao, Jianxia Tang, Lu Zhang, Jianrong Dai, Mingtao Zeng, Shan Lu, Yinchang Zhu, Chuan Su

61

6. BCG Δzmp1 vaccine induces enhanced antigen specific immune responses in cattle Original Research Article

Pages 779-784 Bhagwati Khatri, Adam Whelan, Derek Clifford, Agnese Petrera, Peter Sander, H. Martin Vordermeier

7. Intention to accept Bordetella pertussis booster vaccine during pregnancy in Mexico City Original Research Article

Pages 785-792 Aiden Kennedy Varan, Alejandra Esteves-Jaramillo, Vesta Richardson, Marcelino Esparza-Aguilar, Patricia Cervantes-Powell, Saad B. Omer

8. Timeliness of routine immunization in a population-based Italian cohort of very preterm infants: Results of the ACTION follow-up project Original Research Article

Pages 793-799 Alberto E. Tozzi, Simone Piga, Carlo Corchia, Domenico Di Lallo, Virgilio Carnielli, Valeria Chiandotto, Maria Cristina Fertz, Silvana Miniaci, Franca Rusconi, Marina Cuttini

9. Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice Original Research Article

Pages 800-808 Sofia E. Magnusson, Karin H. Karlsson, Jenny M. Reimer, Silke Corbach-Söhle, Sameera Patel, Justin M. Richner, Norbert Nowotny, Luisa Barzon, Karin Lövgren Bengtsson, Sebastian Ulbert, Michael S. Diamond, Linda Stertman

10. The outer membrane protein, LamB (maltoporin), is a versatile vaccine candidate among the Vibrio species Original Research Article

Pages 809-815 Jingsheng Lun, Changyan Xia, Chuanfei Yuan, Yueling Zhang, Mingqi Zhong, Tongwang Huang, Zhong Hu

11. Prenatal vitamin A deficiency impairs adaptive immune responses to pentavalent rotavirus vaccine (RotaTeq®) in a neonatal gnotobiotic pig model Original Research Article

Pages 816-824 Sukumar Kandasamy, Kuldeep S. Chattha, Anastasia N. Vlasova, Linda J. Saif

12. Evaluation of humoral and cellular immune responses to BP26 and OMP31 epitopes in the attenuated Brucella melitensis vaccinated sheep Original Research Article

Pages 825-833 Wenjing Wang, Jingbo Wu, Jun Qiao, Yunceng Weng, Hui Zhang, Qingyu Liao, Jinlang Qiu, Chuangfu Chen, Jean-Pierre Allain, Chengyao Li

62

13. How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization Original Research Article

Pages 834-838 Mercy Mvundura, Vu Duy Kien, Nguyen Tuyet Nga, Joanie Robertson, Nguyen Van Cuong, Ho Thanh Tung, Duong Thi Hong, Carol Levin

14. Effects of different promoters on the virulence and immunogenicity of a HIV- 1 Env-expressing recombinant vaccinia vaccine Original Research Article

Pages 839-845 Mao Isshiki, Xianfeng Zhang, Hirotaka Sato, Takashi Ohashi, Makoto Inoue, Hisatoshi Shida

15. Indicators of influenza and pneumococcal vaccination in French nursing home residents in 2011 Original Research Article

Pages 846-851 Philipe de Souto Barreto, Maryse Lapeyre-Mestre, Bruno Vellas, Yves Rolland

16. Hepatitis B vaccine immunogenicity among adults vaccinated during an outbreak response in an assisted living facility—Virginia, 2010 Original Research Article

Pages 852-856 Thomas John Bender, Umid Sharapov, Okey Utah, Jian Xing, Dale Hu, Jolanta Rybczynska, Jan Drobeniuc, Saleem Kamili, Philip R. Spradling, Anne C. Moorman

17. Seasonal influenza vaccine effectiveness against influenza in 2012–2013: A hospital-based case-control study in Lithuania Original Research Article

Pages 857-863 Giedre Gefenaite, Janette Rahamat-Langendoen, Arvydas Ambrozaitis, Aukse Mickiene, Ligita Jancoriene, Monika Kuliese, Daiva Velyvyte, Hubert Niesters, Ronald P. Stolk, Kestutis Zagminas, Eelko Hak

18. Tricomponent fusion complex comprising a viral antigen, a pentameric α- helical coiled-coil, and an immunoglobulin-binding domain as an effective antiviral vaccine Original Research Article

Pages 864-871 Takeshi Arakawa, Tetsuya Harakuni, Takeshi Miyata, Senji Tafuku, Masayuki Tadano

19. Rhesus macaque rectal and duodenal tissues exhibit B-cell sub-populations distinct from peripheral blood that continuously secrete antigen-specific IgA in short-term explant cultures Original Research Article

Pages 872-880 Michael A. Thomas, Thorsten Demberg, Diego A. Vargas-Inchaustegui, Peng Xiao, Iskra Tuero, David Venzon, Deborah Weiss, James Treece, Marjorie

63

Robert-Guroff

20. Leptin and leptin-related gene polymorphisms, obesity, and influenza A/H1N1 vaccine-induced immune responses in older individuals Original Research Article

Pages 881-887 Inna G. Ovsyannikova, Sarah J. White, Beth R. Larrabee, Diane E. Grill, Robert M. Jacobson, Gregory A. Poland

21. Interchangeability of Quinvaxem during primary vaccination schedules: Results from a phase IV, single-blind, randomized, controlled, single-center, non-inferiority study Original Research Article

Pages 888-894 Maria Rosario Z. Capeding, Corina Jica, Anna Macura-Biegun, Martina Rauscher, Edison Alberto

Visual Vaccinology Section

22. Bifurcated vaccination needle

Pages 895 Andrew W. Artenstein

Tabla de Contenidos. Volume 32, Issue 6, Pages 639 - 754 (3 February 2014).

1. Editorial Board/Aims and Scope

Pages CO2

Regular papers

2. Tetanus in Italy 2001–2010: A continuing threat in older adults Original Research Article

Pages 639-644 Antonietta Filia, Antonino Bella, Christina von Hunolstein, Antonella Pinto, Giovanna Alfarone, Silvia Declich, Maria Cristina Rota

3. Risk of febrile convulsions after MMRV vaccination in comparison to MMR or MMR+V vaccination Original Research Article

Pages 645-650

64

Tania Schink, Jakob Holstiege, Frank Kowalzik, Fred Zepp, Edeltraut Garbe

4. Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants Original Research Article

Pages 651-656 Mohan Babu Appaiahgari, Roger Glass, Shakti Singh, Sunita Taneja, Temsunaro Rongsen-Chandola, Nita Bhandari, Sukhdev Mishra, Sudhanshu Vrati

5. Antibody but not memory B-cell responses are tuned-down in vertically HIV- 1 infected children and young individuals being vaccinated yearly against influenza Original Research Article

Pages 657-663 Stefano Rinaldi, Paola Zangari, Nicola Cotugno, Emma Concetta Manno, Noemi Brolatti, Maria Rita Castrucci, Isabella Donatelli, Paolo Rossi, Paolo Palma, Alberto Cagigi

6. BacMam virus-based surface display of the infectious bronchitis virus (IBV) S1 glycoprotein confers strong protection against virulent IBV challenge in chickens Original Research Article

Pages 664-670 Jie Zhang, Xiao-Wei Chen, Tie-Zhu Tong, Yu Ye, Ming Liao, Hui-Ying Fan

7. Inferring the antigenic epitopes for highly pathogenic avian influenza H5N1 viruses Original Research Article

Pages 671-676 Yousong Peng, Yuanqiang Zou, Honglei Li, Kenli Li, Taijiao Jiang

8. Optimal timing of influenza vaccination in patients with human immunodeficiency virus: A Markov cohort model based on serial study participant hemoagglutination inhibition titers Original Research Article

Pages 677-684 Gregory R. Werker, Behnam Sharif, Huiying Sun, Curtis Cooper, Nick Bansback, Aslam H. Anis

9. Characterization of protective immune responses promoted by human antigen targets in a urogenital Chlamydia trachomatis mouse model Original Research Article

Pages 685-692 Anja Weinreich Olsen, Peter Andersen, Frank Follmann

10. Randomized controlled trial of two dosing schedules for human papillomavirus vaccination among college age males Original Research Article

Pages 693-699

65

Chyongchiou Jeng Lin, Richard K. Zimmerman, Mary Patricia Nowalk, Hsin- Hui Huang, Jonathan M. Raviotta

11. Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response Original Research Article

Pages 700-705 Michael Maynard-Smith, Helen Ahern, Joanna McGlashan, Philip Nugent, Roger Ling, Harriet Denton, Ruth Coxon, John Landon, April Roberts, Clifford Shone

12. Co-colonization by Haemophilus influenzae with Streptococcus pneumoniae enhances pneumococcal-specific antibody response in young children Original Research Article

Pages 706-711 Qingfu Xu, Michael E. Pichichero

13. Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis Original Research Article

Pages 712-716 Swati Singh, Iti Saraav, Sadhna Sharma

14. Type I interferon-dependent activation of NK cells by rAd28 or rAd35, but not rAd5, leads to loss of vector-insert expression Original Research Article

Pages 717-724 Matthew J. Johnson, Niklas K. Björkström, Constantinos Petrovas, Frank Liang, Jason G.D. Gall, Karin Loré, Richard A. Koup

15. Overcoming barriers to HPV vaccination: Non-inferiority of antibody response to human papillomavirus 16/18 vaccine in adolescents vaccinated with a two-dose vs. a three-dose schedule at 21 months Original Research Article

Pages 725-732 Eduardo Lazcano-Ponce, Margaret Stanley, Nubia Muñoz, Leticia Torres, Aurelio Cruz-Valdez, Jorge Salmerón, Rosalba Rojas, Rolando Herrero, Mauricio Hernández-Ávila

16. Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths Original Research Article

Pages 733-739 Georges Van Kriekinge, Xavier Castellsagué, David Cibula, Nadia Demarteau

17. The impact of the vaccination program for hemorrhagic fever with renal syndrome in Hu County, China Original Research Article

Pages 740-745

66

Dan Xiao, Kejian Wu, Xin Tan, Tiecheng Yan, Haitao Li, Yongping Yan

18. Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies Original Research Article

Pages 746-754 James K. Coleman, Ruiyu Pu, Marcus M. Martin, Ezra N. Noon-Song, Raphael Zwijnenberg, Janet K. Yamamoto

67